Literature DB >> 1315760

A phenylalanine in peptide substrates provides for selectivity between cGMP- and cAMP-dependent protein kinases.

J L Colbran1, S H Francis, A B Leach, M K Thomas, H Jiang, L M McAllister, J D Corbin.   

Abstract

Bovine lung cGMP-binding cGMP-specific phosphodiesterase (cG-BPDE) is a potent and relatively specific substrate for cGMP-dependent protein kinase (cGK) as compared to cAMP-dependent protein kinase (cAK) (Thomas, M. K., Francis, S. H., and Corbin, J. D. (1990) J. Biol. Chem. 265, 14971-14978). A synthetic peptide, RKISASEFDRPLR (BPDEtide), was synthesized corresponding to the sequence surrounding the phosphorylation site in cG-BPDE. BPDEtide retained the cGK/cAK kinase specificity demonstrated by native cG-BPDE: the apparent Km of BPDEtide for cGK was 5-fold lower than that for cAK (Km = 68 and 320 microM, respectively). Vmax values were 11 mumol/min/mg for cGK and 3.2 mumol/min/mg for cAK. The peptide was not phosphorylated to a measurable extent by protein kinase C or by calcium/calmodulin-dependent protein kinase II. Thus, the primary amino acid sequence of the peptide substrate was sufficient to confer kinase specificity. Studies in crude tissue extracts indicated that BPDEtide was the most selective peptide substrate documented for measuring cGK activity. Peptide analogs of BPDEtide were synthesized to determine the contribution of specific residues to cGK or cAK substrate specificity. Substitution of a Lys for the amino-terminal Arg did not reduce cGK/cAK specificity; neither did the exchange of an Ala for the non-phosphorylated Ser nor the removal of the 3 carboxyl-terminal residues. A truncated BPDEtide (RKISASE) served equally well as substrate (Km approximately 90 microM) for both kinases. However, restoration of the Phe, to yield RKISASEF, reproduced the original cGK/cAK specificity for BPDEtide (Km = 120 and 480 microM, respectively), primarily by decreasing the affinity of cAK. Addition of a carboxyl-terminal Phe to the peptide RKRSRAE (derived from the sequence of the cGK phosphorylation site in histone H2B) or to the peptide LRRASLG (derived from the sequence of the cAK phosphorylation site in pyruvate kinase) also improved the cGK/cAK specificity by decreasing the affinity of cAK. These data suggested that the Phe in each substrate tested is a negative determinant for cAK.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1315760

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Novel peptide for attenuation of hypoxia-induced pulmonary hypertension via modulation of nitric oxide release and phosphodiesterase -5 activity.

Authors:  Hanbo Hu; Sergey Zharikov; Jawaharlal M Patel
Journal:  Peptides       Date:  2012-03-20       Impact factor: 3.750

2.  Binding of cGMP to both allosteric sites of cGMP-binding cGMP-specific phosphodiesterase (PDE5) is required for its phosphorylation.

Authors:  I V Turko; S H Francis; J D Corbin
Journal:  Biochem J       Date:  1998-02-01       Impact factor: 3.857

3.  Phosphorylation of septin 3 on Ser-91 by cGMP-dependent protein kinase-I in nerve terminals.

Authors:  Jing Xue; Peter J Milburn; Bernadette T Hanna; Mark E Graham; John A P Rostas; Phillip J Robinson
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

4.  Protein kinase G regulates the basal tension and plays a major role in nitrovasodilator-induced relaxation of porcine coronary veins.

Authors:  H Qi; X Zheng; X Qin; D Dou; H Xu; J U Raj; Y Gao
Journal:  Br J Pharmacol       Date:  2007-09-24       Impact factor: 8.739

5.  Primary structure and functional expression of a cGMP-gated potassium channel.

Authors:  X Yao; A S Segal; P Welling; X Zhang; C M McNicholas; D Engel; E L Boulpaep; G V Desir
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

6.  High blood pressure arising from a defect in vascular function.

Authors:  Simon K Michael; Howard K Surks; Yuepeng Wang; Yan Zhu; Robert Blanton; Michelle Jamnongjit; Mark Aronovitz; Wendy Baur; Kenichi Ohtani; Michael K Wilkerson; Adrian D Bonev; Mark T Nelson; Richard H Karas; Michael E Mendelsohn
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-30       Impact factor: 11.205

7.  Mode of action of cGMP-dependent protein kinase-specific inhibitors probed by photoaffinity cross-linking mass spectrometry.

Authors:  Martijn W H Pinkse; Dirk T S Rijkers; Wolfgang R Dostmann; Albert J R Heck
Journal:  J Biol Chem       Date:  2009-04-15       Impact factor: 5.157

Review 8.  Signalling by cGMP-dependent protein kinases.

Authors:  A B Vaandrager; H R de Jonge
Journal:  Mol Cell Biochem       Date:  1996 Apr 12-26       Impact factor: 3.396

9.  Study of the affinity between the protein kinase PKA and peptide substrates derived from kemptide using molecular dynamics simulations and MM/GBSA.

Authors:  Karel Mena-Ulecia; Ariela Vergara-Jaque; Horacio Poblete; William Tiznado; Julio Caballero
Journal:  PLoS One       Date:  2014-10-02       Impact factor: 3.240

Review 10.  Phosphodiesterase Inhibitors as a Therapeutic Approach to Neuroprotection and Repair.

Authors:  Eric P Knott; Mazen Assi; Sudheendra N R Rao; Mousumi Ghosh; Damien D Pearse
Journal:  Int J Mol Sci       Date:  2017-03-24       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.